Alana B. Mcnulty - Net Worth and Insider Trading

Alana B. Mcnulty Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Alana B. Mcnulty owns 3 companies in total, including Janux Therapeutics Inc (JANX) , eFFECTOR Therapeutics Inc (EFTR) , and Graf Acquisition Corp IV (GFOR) .

Click here to see the complete history of Alana B. Mcnulty’s form 4 insider trades.

Insider Ownership Summary of Alana B. Mcnulty

Ticker	Comapny	Transaction Date	Type of Owner
JANX	Janux Therapeutics Inc	2021-09-07	director
EFTR	eFFECTOR Therapeutics Inc	2021-08-25	Chief Business Officer
GFOR	Graf Acquisition Corp IV	2023-09-29	director

Alana B. Mcnulty Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Alana B. Mcnulty Ownership Network

Ownership Network List of Alana B. Mcnulty

No Data

Ownership Network Relation of Alana B. Mcnulty

Alana B. Mcnulty Owned Company Details

What does Janux Therapeutics Inc do?

Who are the key executives at Janux Therapeutics Inc?

Alana B. Mcnulty is the director of Janux Therapeutics Inc. Other key executives at Janux Therapeutics Inc include director & 10 percent owner Jay Lichter , 10 percent owner Avalon Ventures Xi, L.p. , and 10 percent owner & Acting Chief Financial Officer Tighe Reardon .

Janux Therapeutics Inc (JANX) Insider Trades Summary

Over the past 18 months, Alana B. Mcnulty made no insider transaction in Janux Therapeutics Inc (JANX). Other recent insider transactions involving Janux Therapeutics Inc (JANX) include a net sale of 650,146 shares made by Avalon Ventures Xi, L.p. , a net sale of 650,146 shares made by Jay Lichter , and a net purchase of 27,133 shares made by Tighe Reardon .

In summary, during the past 3 months, insiders sold 3,822,721 shares of Janux Therapeutics Inc (JANX) in total and bought 0 shares, with a net sale of 3,822,721 shares. During the past 18 months, 3,822,721 shares of Janux Therapeutics Inc (JANX) were sold and 3,044,570 shares were bought by its insiders, resulting in a net sale of 778,151 shares.

Janux Therapeutics Inc (JANX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Janux Therapeutics Inc Insider Transactions

No Available Data

What does eFFECTOR Therapeutics Inc do?

Who are the key executives at eFFECTOR Therapeutics Inc?

Alana B. Mcnulty is the Chief Business Officer of eFFECTOR Therapeutics Inc. Other key executives at eFFECTOR Therapeutics Inc include 10 percent owner Sr One Capital Fund I Aggregator Lp , director & 10 percent owner & Chief Executive Officer Christopher B Ehrlich , and Chief Business Officer Mayank Gandhi .

eFFECTOR Therapeutics Inc (EFTR) Insider Trades Summary

Over the past 18 months, Alana B. Mcnulty made no insider transaction in eFFECTOR Therapeutics Inc (EFTR). Other recent insider transactions involving eFFECTOR Therapeutics Inc (EFTR) include a net sale of 609,163 shares made by Sr One Capital Fund I Aggregator Lp ,

In summary, during the past 3 months, insiders sold 0 shares of eFFECTOR Therapeutics Inc (EFTR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 24,367 shares of eFFECTOR Therapeutics Inc (EFTR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 24,367 shares.

eFFECTOR Therapeutics Inc (EFTR)'s detailed insider trading history can be found in Insider Trading Tracker table.

eFFECTOR Therapeutics Inc Insider Transactions

No Available Data

What does Graf Acquisition Corp IV do?

Who are the key executives at Graf Acquisition Corp IV?

Alana B. Mcnulty is the director of Graf Acquisition Corp IV. Other key executives at Graf Acquisition Corp IV include Chief Operating Officer Pierre Gagnon , director & 10 percent owner & other: See Remarks Sangwoo Park , and CSO and CIO Yong Man Kim .

Graf Acquisition Corp IV (GFOR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Graf Acquisition Corp IV (GFOR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Graf Acquisition Corp IV (GFOR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Graf Acquisition Corp IV (GFOR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Graf Acquisition Corp IV Insider Transactions

No Available Data

Alana B. Mcnulty Mailing Address

Above is the net worth, insider trading, and ownership report for Alana B. Mcnulty. You might contact Alana B. Mcnulty via mailing address: C/o Lumena Pharmaceuticals, Inc., 12531 High Bluff Drive, Suite 110, San Diego Ca 92130.

Discussions on Alana B. Mcnulty

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.